NKGen Biotech, Inc. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
NKGen Biotech, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2022 to Q2 2024.
  • NKGen Biotech, Inc. Deferred Income Tax Liabilities, Net for the quarter ending June 30, 2024 was $33K.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $33K Jun 30, 2024 10-Q 2024-09-12
Q1 2024 $33K Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $33K +$7K +26.9% Dec 31, 2023 10-Q 2024-09-12
Q3 2023 $26K Sep 30, 2023 10-Q 2023-11-14
Q4 2022 $26K Dec 31, 2022 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.